March 16, 2016
(The Guardian) – Unfortunately, ethical and social concerns have not held much sway over recent biosciences policy in the UK. Despite a lack of consensus about its acceptability, the UK Human Fertilisation and Embryology Authority recently approved the use of CRISPR/Cas9 to genetically modify genes in healthy human embryos. This came shortly after regulatory approval for mitochondrial DNA transfer, the ‘three parent’ IVF technique, despite it being subject to much controversy.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.